Rivastigmine for dementia associated with Parkinson's disease


Emre M., Aarsland D., Albanese A., Byrne E., Deuschl G., De Deyn P., ...More

NEW ENGLAND JOURNAL OF MEDICINE, vol.351, no.24, pp.2509-2518, 2004 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 351 Issue: 24
  • Publication Date: 2004
  • Doi Number: 10.1056/nejmoa041470
  • Journal Name: NEW ENGLAND JOURNAL OF MEDICINE
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.2509-2518

Abstract

Background: Cholinergic deficits are prominent in patients who have dementia associated with Parkinson's disease. We investigated the effects of the dual cholinesterase inhibitor rivastigmine in such patients.